Chiome Bioscience Inc. announced consolidated earnings results for the six months ended June 30, 2017. For the period, the company reported net sales of JPY 102 million against net sales of JPY 130 million a year ago. Operating loss was JPY 388 million against operating loss of JPY 582 million a year ago. Ordinary loss was JPY 389 million against ordinary loss of JPY 580 million a year ago. Net loss was JPY 389 million against net loss of JPY 711 million a year ago. Net loss per share was JPY 15.02 against net loss per share of JPY 31.99 a year ago. Loss before taxes was JPY 388.32 million against loss before taxes of JPY 709.8 million a year ago. Net cash used in operating activities of JPY 569.6 million against net cash used in operating activities of JPY 385.9 million a year ago. Purchase of property and equipment was JPY 5.916 million against purchase of property and equipment of JPY 4.975 million a year ago.